Highlights
NASDAQ: CRTX       Cortexyme Inc
Last Price Today's Change   Day's Range   Trading Volume
44.44   -1.65 (3.58%)  42.40 - 46.99  521,500

Overview

 
Avg Volume (4 weeks):201,600
4 Weeks Range:41.38 - 58.94
4 Weeks Price Volatility (%):
17.43%
52 Weeks Range:19.35 - 73.84
52 Weeks Price Volatility (%):
46.05%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company's promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty pharmaceutical company, focused on developing hospital products for cardiovascular indications. In March 2012, it acquired the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets. In June 2012, the Company acquired EKR Therapeutics, Inc. In February 2014, Chiesi Farmaceutici S.p.A acquired Cornerstone Therapeutics Inc.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5548  2619  509  162 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CETX 2.58+1.633 
 VISL 0.36+0.066 
 DGLY 1.97+0.85 
 GE 6.76+0.19 
 AESE 3.96+1.51 
 PFE 35.46-2.73 
 NIO 4.26+0.28 
 NCLH 17.29+1.63 
 F 5.87+0.16 
 HTZ 0.89-0.11 
Partners & Brokers